Consequently, differentiating between GCB and non-GCB groups based solely on Ki67 with AI modeling proved challenging, suggesting that predicting high-risk and low-risk classes should be considered independent of DLBCL subtype classification. This evidence concerns the gene MKI67 and diffuse large B-cell lymphoma.